Preclinical evaluation of oncolytic δγ(1)34.5 herpes simplex virus expressing interleukin-12 for therapy of breast cancer brain metastases.

Int J Breast Cancer · 2012 · PMC3549352 · PMID 23346408

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

In contrast, infected cells yielded a high level of IL-12 production across all three time points, with a slight trend towards maximum production at 48 h ( Figure 1 ).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.